Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 8 February 2024

 
 
 
   

Blogs
 

Patient engagement: accelerating progress in a spirit of partnership
06 February 2024

Training, sharing best practices and measuring impact are key to moving patients centre stage, according to a survey... Read more
 
 
 
   

EJP RD-EFPIA Joint Webinar - Recording Now Available

For those unable to take part in the live event, have a look at the recorded sessions, featuring keynote speaker presentations and insightful discussions on Real-World Data, Machine Learning, and Deep Analytics in rare diseases.
 
 
 
 
   

Events
 

Getting to the heart of the matter: improving cardiovascular health in Europe
20 February 2024 (Virtual event)

Join us to be at the forefront of shaping cardiovascular health management in the EU. Read more

International Congress on Rare Diseases and Orphan Drugs
29 February 2024 (Athens and online)

Navigating the Uncharted: Advancements, Collaborations, and Hope in Rare Diseases Read more

Digitally-enabled healthcare: Is our ecosystem on track?
07 March 2024 (Brussels and online)

Organised by the EU Health Coalition. Read more

Regulatory Reliance Tools Unveiled: A Practical Guide by EMA
19 March 2024 (Virtual event)

Jointly organised by six industry partners. Read more
 
 
 
   

Recently published

 

Tackling inequalities: how can Europe beat cancer everywhere?
31 January 2024 (News & Events)

New study reveals stark differences in spending and patient outcomes across the EU Read more

Cardiovascular disease: LSE-report highlights life-saving potential of secondary prevention...
23 January 2024 (News & Events)

More than 1 million fatal heart attacks & strokes could be prevented with better management of four risk factors Read more
 
 
 
   

What we are reading
 
Lessons in innovation: unpacking europe's beating cancer plan and its blueprint for sustainable...
On 07 February 2024 (Merck)

Leveraging data and innovation, in combination with clear ethical guidance, could revolutionize the impact of cancer.... Read more
How do patients benefit from H2O?
On 07 February 2024 (H20 website)

The H2O brings together the public and private sectors to create an unprecedented, standardised data governance and... Read more
Poland’s health priorities get focused ahead of its 2025 EU presidency
On 06 February 2024 (Euractiv)

Poland’s priorities for its 2025 presidency of the Council of the EU are set to focus on the digital transformation... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu
EFPIA 2024 All rights reserved Disclaimer